BioPharmaTrend
Latest Insights
Companies
  • Companies Directory
  • Case Studies
Newsletter
About
  • At a Glance
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
 
 Subscribe 
Sign in
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Business Intelligence
Back to Companies Directory

Deep Intelligent Pharma

Deep Intelligent Pharma logo

Website
https://www.dip-ai.com/home-multi-lang/?lang=en#/
Founded
2017

Technologies

AI Companies (Drug Discovery) Pharmaceutical and Drug Discovery

Beijing Deep Intelligent Pharma Technology Co., Ltd. operates an artificial intelligence (AI) technology and blockchain technology driven platform, which enables pharmaceutical companies to drug discovery, development, and medical affairs. Its products include medical translations, which is a multi-language medical machine translation engine; intelligent pharmacovigilance, provides risk management solutions throughout the whole product life cycle, for overcoming the slow pace of safety and signal detection; A.I.M medical, which helps in creation and delivery of multilingual educational materials and publications; intelligent medical writing, which helps pharmaceutical companies develop AI enabled writing tools, including automatic writing, tabulated data analysis, document review, and quality control; patient search ecosystem, creates a new ecosystem for medical and clinical research, helping different roles on the platform to find the relevant information; and intelligent regulatory affairs, intelligent solutions for regulatory affairs and also for drug research and development.

Main products for Drug Discovery:
- Knowledge Graph
- Drug Discovery Platform
- Organic Synthesis System
- Clinical Data Platform

R&D Platform

This is an AI-Powered organic synthesis system assisting chemists to synthesize target compounds successfully through more efficient and intelligent processes. It utilizes Deep Learning technology to build prediction models by digesting and learning millions of chemical reaction data. With one-click approach, it generates multiple full retrosynthesis routes and essential reaction related information for target compounds.

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Press & Citations
  • Terms of Use
  • Privacy Policy
  • Cookies Policy
  • Disclaimer

Topics


  • News
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures

Explore


  • Premium Insights
  • Business Intelligence
  • Companies
  • Events
  • Authors

Partner


  • Sponsorship
  • Editorial Calendar

© WTMB Research & Media, S.L. (WTMB Group)   2026
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.